ZA977960B - Graft survival prolongation with porphyrins. - Google Patents

Graft survival prolongation with porphyrins.

Info

Publication number
ZA977960B
ZA977960B ZA9707960A ZA977960A ZA977960B ZA 977960 B ZA977960 B ZA 977960B ZA 9707960 A ZA9707960 A ZA 9707960A ZA 977960 A ZA977960 A ZA 977960A ZA 977960 B ZA977960 B ZA 977960B
Authority
ZA
South Africa
Prior art keywords
porphyrins
graft survival
survival prolongation
prolongation
graft
Prior art date
Application number
ZA9707960A
Other languages
English (en)
Inventor
Roland Buelow
Jacky Woo
Suhasini Iyer
Original Assignee
Sangstat Medical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sangstat Medical Corp filed Critical Sangstat Medical Corp
Publication of ZA977960B publication Critical patent/ZA977960B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Dentistry (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA9707960A 1996-09-09 1997-09-04 Graft survival prolongation with porphyrins. ZA977960B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/709,650 US5756492A (en) 1996-09-09 1996-09-09 Graft survival prolongation with porphyrins

Publications (1)

Publication Number Publication Date
ZA977960B true ZA977960B (en) 1998-03-02

Family

ID=24850771

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9707960A ZA977960B (en) 1996-09-09 1997-09-04 Graft survival prolongation with porphyrins.

Country Status (8)

Country Link
US (2) US5756492A (xx)
EP (1) EP0865275A2 (xx)
JP (1) JP3287851B2 (xx)
AR (1) AR009560A1 (xx)
AU (1) AU740531B2 (xx)
CA (1) CA2234886A1 (xx)
WO (1) WO1998009618A2 (xx)
ZA (1) ZA977960B (xx)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127356A (en) 1993-10-15 2000-10-03 Duke University Oxidant scavengers
ES2198767T3 (es) 1997-11-03 2004-02-01 Duke University Porfirinas sustituidas.
AR024523A1 (es) * 1998-12-17 2002-10-16 Sangstat Medical Corp Metodo para aumentar la sobrevida de un injerto por modulacion de la actividad de hemo oxigenasa
JP4501128B2 (ja) * 1999-01-25 2010-07-14 ナショナル ジュウィッシュ ヘルス 置換ポルフィリン
EP1153010A1 (en) 1999-02-08 2001-11-14 Checkpoint Genetics, Inc. $i(N)-SUBSTITUTED AMINO ACIDS, ANTIOXIDANT PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND METHODS USING SAME
US7235649B2 (en) * 2000-03-24 2007-06-26 Duke University Isolated GRP94 ligand binding domain polypeptide and nucleic acid encoding same, and screening methods employing same
US20030069281A1 (en) * 2000-06-14 2003-04-10 Irwin Fridovich Tetrapyrroles
CA2436245C (en) * 2001-01-19 2013-04-23 National Jewish Medical And Research Center Medicament for protection in radiotherapy
GB0111872D0 (en) * 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
AU2002312194B8 (en) * 2001-06-01 2008-05-15 Aeolus Sciences, Inc. Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance
WO2003051347A1 (en) * 2001-12-19 2003-06-26 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Use of urokinase receptor antagonists to modulate ischemiareperfusion injury
JP2005519928A (ja) * 2002-02-04 2005-07-07 ハース，ベルナー Ｃｏ放出能力を有する化合物の投与によって哺乳動物を治療する方法と、ｃｏ放出能力を有する化合物ならびにその医薬組成物
US20080026984A1 (en) * 2002-02-04 2008-01-31 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
US7968605B2 (en) * 2002-02-04 2011-06-28 ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
US20040143025A1 (en) * 2002-04-01 2004-07-22 Roland Buelow Carbon monoxide generating compunds for treatment of vascular, inflammatory and immune disorders
WO2003088748A1 (en) 2002-04-15 2003-10-30 Beth Israel Deaconess Medical Center Use of heme oxygenase-1 and products of heme degradation
AU2003237500A1 (en) * 2002-06-07 2003-12-22 Duke University Substituted porphyrins
GB2395432B (en) * 2002-11-20 2005-09-14 Northwick Park Inst For Medica Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
GB2397067B (en) * 2002-12-23 2005-05-11 Destiny Pharma Ltd Porphin & azaporphin derivatives with at least one cationic-nitrogen-containing meso-substituent for use in photodynamic therapy & in vitro sterilisation
GB2415372A (en) 2004-06-23 2005-12-28 Destiny Pharma Ltd Non photodynamical or sonodynamical antimicrobial use of porphyrins and azaporphyrins containing at least one cationic-nitrogen-containing substituent
US20090149436A1 (en) * 2004-11-16 2009-06-11 Astellas Pharma Inc. Caspase inhibitor
EP1762248A1 (en) * 2005-09-09 2007-03-14 CORIT Consorzio per la Ricerca sul Use of cobalt porphyrins in joint therapy with an immunosuppressant drug for treatment of transplant patients or autoimmune disorders
WO2007073226A1 (en) * 2005-12-20 2007-06-28 Alfama - Investigação E Desenvolvimento De Produtos Farmacêuticos Lda Method for treating a mammal by administration of a compound having the ability to release co
GB0601394D0 (en) 2006-01-24 2006-03-01 Hemocorm Ltd Therapeutic delivery of carbon monoxide
EP2300003B1 (en) 2008-05-23 2014-03-05 National Jewish Health Compounds for use in treating injury associated with exposure to an alkylating species
JP5978291B2 (ja) 2011-04-19 2016-08-24 アルファーマ インコーポレイテッドＡｌｆａｍａ，Ｉｎｃ． 一酸化炭素放出分子およびその使用
ES2628634T3 (es) 2011-07-21 2017-08-03 Alfama, Inc. Moléculas liberadoras de monóxido de carbono-rutenio y usos de las mismas
CN103930103B (zh) 2011-10-12 2016-08-24 思佰益药业股份有限公司 移植器官的成活促进剂
HUE043511T2 (hu) 2012-07-13 2019-08-28 Sbi Pharmaceuticals Co Ltd Immuntoleranciát kiváltó szer
WO2018144845A1 (en) * 2017-02-03 2018-08-09 The Board Of Trustees Of The Leland Stanford Junior University Metalloporphyrin microparticles for treatment of anemia and tropical diseases
WO2023287665A1 (en) * 2021-07-12 2023-01-19 Renibus Therapeutics, Inc. Metal protoporphyrin for treatment of bk virus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4829984A (en) * 1983-12-15 1989-05-16 Gordon Robert T Method for the improvement of transplantation techniques and for the preservation of tissue
US5563132A (en) * 1994-06-21 1996-10-08 Bodaness; Richard S. Two-step cancer treatment method
CA2132690A1 (en) * 1994-09-22 1996-03-23 Dean Willis Control and modulation of inflammatory response in humans in need of such control and modulation

Also Published As

Publication number Publication date
EP0865275A2 (en) 1998-09-23
JP3287851B2 (ja) 2002-06-04
US6060467A (en) 2000-05-09
WO1998009618A3 (en) 1998-05-07
JPH11507083A (ja) 1999-06-22
AU4734497A (en) 1998-03-26
US5756492A (en) 1998-05-26
WO1998009618A2 (en) 1998-03-12
AU740531B2 (en) 2001-11-08
CA2234886A1 (en) 1998-03-12
AR009560A1 (es) 2000-04-26

Similar Documents

Publication Publication Date Title
ZA977960B (en) Graft survival prolongation with porphyrins.
GR3022021T3 (en) Flashlight.
ZA9710429B (en) Broad-spectrumδ-endotoxins.
AU4019295A (en) Backpack or waistpack e.l. lighting arrangement
ZA973901B (en) Alternative fuel.
ZA971058B (en) Bodyboard with differentiated topskin.
ZA976168B (en) 3-Ureido-pyridofurans and -pyridothiophenes.
ZA979199B (en) Aminothiophenecarboxamides.
ZA979593B (en) Naphthyridine derivatives.
ZA975013B (en) Modified factor VII.
GB9609148D0 (en) Multi-party communication
ZA975233B (en) Hydroxyphenyltriazines.
ZA978256B (en) Electrolyte.
ZA977206B (en) Arylalkanoylpyridazines.
ZA978304B (en) 3-alkyl-3-phenyl-piperidines.
ZA976492B (en) Substituted pyrroles.
ZA978675B (en) Keypad.
EP0611096A3 (en) Lighter.
ZA976487B (en) Substituted pyrroles.
ZA97572B (en) 1-pyrazol-3-ylethyl-4-indol-3-ylpiperidines.
AU133360S (en) Foldable lighter
ZA977791B (en) GLP-1 derivatives.
GB2312810B (en) Multi-party communication
ZA976022B (en) Cycloalkano-pyridines.
ZA9710318B (en) Safe re-locker.